BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18222210)

  • 1. Resection for esophageal cancer: strategies for optimal management.
    Pennathur A; Luketich JD
    Ann Thorac Surg; 2008 Feb; 85(2):S751-6. PubMed ID: 18222210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
    Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive esophagectomy.
    Gilbert S; Luketich JD
    Adv Surg; 2004; 38():67-83. PubMed ID: 15515615
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.
    Rice TW; Adelstein DJ; Chidel MA; Rybicki LA; DeCamp MM; Murthy SC; Blackstone EH
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1590-6. PubMed ID: 14666038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited commentary.
    Hoover EL
    Ann Thorac Surg; 2007 Apr; 83(4):1278. PubMed ID: 17383326
    [No Abstract]   [Full Text] [Related]  

  • 9. The current role of transhiatal esophagectomy.
    Macha M; Whyte RI
    Chest Surg Clin N Am; 2000 Aug; 10(3):499-518, viii. PubMed ID: 10967753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.
    Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S
    Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited commentary.
    Burfeind W
    Ann Thorac Surg; 2007 Apr; 83(4):1264. PubMed ID: 17383323
    [No Abstract]   [Full Text] [Related]  

  • 14. Robotic esophagectomy: is it an advance and what is the future?
    Watson TJ
    Ann Thorac Surg; 2008 Feb; 85(2):S757-9. PubMed ID: 18222211
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck.
    Motoyama S; Kitamura M; Saito R; Maruyama K; Okuyama M; Ogawa J
    World J Surg; 2006 Feb; 30(2):191-8. PubMed ID: 16425071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis.
    Graham AJ; Shrive FM; Ghali WA; Manns BJ; Grondin SC; Finley RJ; Clifton J
    Ann Thorac Surg; 2007 Apr; 83(4):1257-64. PubMed ID: 17383322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma.
    Katayama A; Mafune K; Tanaka Y; Takubo K; Makuuchi M; Kaminishi M
    J Am Coll Surg; 2003 Jun; 196(6):866-73. PubMed ID: 12788422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
    Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.